News
2016
company
year
domain
Syros Pharmaceuticals Presents New Data Demonstrating Significant Anti - Tumor Activity of its Selective CDK7 Inhibitor in Preclinical Models of Acute Myeloid Leukemia
Syros Pharmaceuticals 04.20.2016
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti - Cancer Activity of SY - 1425 in Preclinical Models of Acute Myeloid Leukemia
Syros Pharmaceuticals 04.18.2016